Cardiovascular disease and colorectal cancer: A population-based observation in Taiwan

Kuwait Medical Journal

Volumn 45, Issue 1, 2013, Pages 31-36

  Lai, Shih Wei ^a,b   Liao, Kuan Fu ^b,c   Lai, Hsueh Chou ^c,d   Tsai, Pang Yao ^b,e   Sung, Fung Chang ^b,e   Chen, Pei Chun ^f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cardiovascular disease; Colorectal adenoma; Colorectal cancer

Indexed keywords

ADULT; AGE; AGED; ALCOHOLISM; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; SEX DIFFERENCE; SMOKING; TAIWAN;

EID: 84874899905     PISSN: 00235776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
2. Boyle P, Leon ME. Epidemiology of colorectal cancer. Br Med Bull 2002; 64:1-25.
3. Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006; 107:28-36.
4. Stocks T, Lukanova A, Bjørge T, et al. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer 2011; 117:2398-2407.
5. Kabat GC, Kim MY, Peters U, et al. A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women. Eur J Cancer Prev 2012; 21:326-332.
6. Pais R, Silaghi H, Silaghi AC, et al. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009; 15:5141-5148.
7. Siddiqui AA. Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci 2011; 341:227-231.
8. Ninomiya JK, L'Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109:42-46.
9. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119:812-819.
10. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49:403-414.
11. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol 2010; 56:1113-1132.
12. Zambon A, Pauletto P, Crepaldi G. Review article: the metabolic syndrome - a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther 2005; 22:S20-S23.
13. Reddy KJ, Singh M, Bangit JR, Batsell RR. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med (Hagerstown) 2010; 11:633-647.
14. Department of Health. Taiwan: Main Causes of Death in 2010. http://www.doh.gov.tw [cited May 10, 2012].
15. Chien KL, Hsu HC, Sung FC, et al. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 2007; 194:114-221.
16. Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 2010; 89:295-299.
17. Lai SW, Su LT, Lin CH, et al. Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: A population-based study. Psychogeriatrics 2011; 11:150-156.
18. Lai SW, Muo CH, Liao KF, et al. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol 2011; 106:1697-1704.
19. Lai SW, Chen PC, Liao KF, et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol 2012; 107:46-52.
20. Liao KF, Lai SW, Li CI, Chen WC. Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan. J Gastroenterol Hepatol 2012; 27:709-713.
21. Sennerby U, Farahmand B, Ahlbom A, et al. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 2007; 18:1355-1362.
22. Sennerby U, Melhus H, Gedeborg R, et al. Cardiovascular diseases and risk of hip fracture. JAMA 2009; 302:1666-1673.
23. Bond JH. Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. Semin Gastrointest Dis 2000; 11:176-184.
24. Yee YK, Tan VP, Chan P, et al. Epidemiology of colorectal cancer in Asia. J Gastroenterol Hepatol 2009; 24:1810-1816.
25. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22:191-197.
26. Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7:676-681.